2011
DOI: 10.3390/molecules16064897
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and In Vitro Protein Tyrosine Kinase Inhibitory Activity of Furan-2-yl(phenyl)methanone Derivatives

Abstract: A series of novel furan-2-yl(phenyl)methanone derivatives were synthesized, and their structures were established on the basis of 1H-NMR, 13C-NMR and mass spectral data. All the prepared compounds were screened for their in vitro protein tyrosine kinase inhibitory activity and several new derivatives exhibited promising activity, which, in some cases, was identical to, or even better than that of genistein, a positive reference compound. The preliminary structure-activity relationships of these compounds were … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
9
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(9 citation statements)
references
References 18 publications
0
9
0
Order By: Relevance
“…In support of these growing interests, we expanded upon the continuing structural optimization and mechanistic investigation on halophenols for finding a candidate compound. As a fact, we have reported the plentiful synthesis of a series of diphenylketone, diphenylmethane and phenyl furan-2-yl ketone halophenols, and their protective activity against H 2 O 2 induced injury in human umbilical vein endothelial cells (HUVECs) [ 11 , 13 ]. Moreover, we indeed found a “hit” compound, 5,2’-dibromo-2,4’,5’-trihydroxydiphenylmethanoe ( LM49 ) ( Figure 1 ) possessing an EC 50 value of 0.4 μM with the strong vascular endothelium protective ability [ 11 ], as evidenced being attributed to its anti-apoptotic, antioxidant, and anti-inflammatory abilities by further mechanical study [ 1 , 14 ].…”
Section: Introductionmentioning
confidence: 99%
“…In support of these growing interests, we expanded upon the continuing structural optimization and mechanistic investigation on halophenols for finding a candidate compound. As a fact, we have reported the plentiful synthesis of a series of diphenylketone, diphenylmethane and phenyl furan-2-yl ketone halophenols, and their protective activity against H 2 O 2 induced injury in human umbilical vein endothelial cells (HUVECs) [ 11 , 13 ]. Moreover, we indeed found a “hit” compound, 5,2’-dibromo-2,4’,5’-trihydroxydiphenylmethanoe ( LM49 ) ( Figure 1 ) possessing an EC 50 value of 0.4 μM with the strong vascular endothelium protective ability [ 11 ], as evidenced being attributed to its anti-apoptotic, antioxidant, and anti-inflammatory abilities by further mechanical study [ 1 , 14 ].…”
Section: Introductionmentioning
confidence: 99%
“…Halophenols, isolated from halobios such as various marine algae, ascidians and sponges exhibit a wide spectrum of bioactivities including protein tyrosine phosphatase (PTP1B) inhibitory [10], antioxidative [11,12], antithrombotic [13], antimicrobial [14,15], anti-inflammatory [16], enzyme inhibitory [17], cytotoxic [18], appetite suppressant [19], and PTK inhibitory activities [20]. Recently, we synthesized a variety of halophenols including 2,4′,5′-trihydroxyl-5,2′-dibromo diphenylmethanone (TDD, Figure 1), which has strong antioxidative and cytoprotective activities [21,22,23]. However, the detailed mechanisms underscoring its actions are unclear.…”
Section: Introductionmentioning
confidence: 99%
“…[ 47 ], where naturally occurring flavonoids have shown their complete retardation (using 100 μM quercetin) and suppression of growth (using apigenin and myricetin). In addition, not only natural (bromo)phenols, but also their synthetic analogs have also shown identical or even better in vitro protein tyrosine kinase inhibitory activity (μM) [ 63 ]. Thus, this could indicate pathway in searching for new chemical entities that could be further developed as therapeutic/chemopreventive agents for prostate cancer.…”
Section: Discussionmentioning
confidence: 99%
“…Subsequently, while tebrophen eliminates PC3 cells and inhibits other studied cell line growth, it is suggested as a starting lead molecule for the design of more soluble derivatives with specific anticancer activity. For that purpose testing on several different prostate cell lines and detailed mechanistic study including tyrosine kinases [ 63 ] have to be performed.…”
Section: Discussionmentioning
confidence: 99%